Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Recent Tweets

$RARE Ultragenyx updates on Stage 1 cohorts in pivotal Cyprus2+ study for UX701 Gene Therapy in Wilson Disease treatment.

More Info: https://pryzm.ozmosi.com/product/25164 $XBI $IBB $XPH $PPH

$TSX:DHT, TSX:DHT.U DRI Healthcare Trust acquires payment streams for CASGEVY® gene-editing technology based on Cas9.

More Info: https://pryzm.ozmosi.com/product/20468 $XBI $IBB $XPH $PPH

$ABVX, PARIS:ABVX, PARIS:FR Abivax initiates enrollment for ENHANCE-CD Phase 2b Trial of Obefazimod in Crohn's Disease with first patient enrolled.

More Info: https://pryzm.ozmosi.com/product/14508 $XBI $IBB $XPH $PPH

$BMY FDA approves treatment regimen of Opdivo with chemotherapy before surgery and Opdivo alone after surgery for resectable NSCLC.

More Info: https://pryzm.ozmosi.com/product/6346 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762